BMRN

+3.5%🟢 Fundamentally supported

BioMarin Pharmaceuticals Inc · Healthcare

$57.06Vol 506.6K · 0.7× normalMkt cap +$0.37Blive · 2026-10-15 ET

What happened

Move

+3.5%

Price

$57.06

Volume

506.6K

0.7× normal

Market cap

$11.05B

+$0.37B today

Why it moved

Acquisition / M&Amedium confidence

1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s Acquisition of Alesta Therapeutics — finnhub-news
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Screens as a Decent Value Stock on Cheap Forward Earnings — finnhub-news

Possible catalyst: acquisition / m&a, 1.6pp above its sector.

Verdict — was the move justified?

🟢 Fundamentally supported

Acquisition / M&A — direction and rough magnitude are consistent with the identified fundamental catalyst.

How unusual is this move

σ score

3.5σ

vs own 20d volatility

Percentile

94th

of 1270 daily moves

Avg daily move

±1.4%

own 5y average

vs sector

+1.6%

beyond sector median

Today’s move is among the largest 6% of BMRN’s daily moves over the last 5 years — while the sector moved +1.9% and the market +1.2%.

What happened after similar moves

101 similar up moves in BMRN’s 5-year history:

After 5 days

-0.4%

47% higher

After 20 days

+0.3%

51% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

V 52G 45P 21H 72Q 60

Insider activity (90d): net selling $1.16M

Valuation context

P/E (TTM)

146.3

5y median 116.1

P/E percentile

55%

vs own 5y history

FCF yield

0.1%

Valuation sits near the middle of its own historical range (55th percentile).

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for BMRN

→